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Abstract: Stem cell technology has attracted considerable attention over recent decades due to its
enormous potential in regenerative medicine and disease therapeutics. Studying the underlying
mechanisms of stem cell differentiation and tissue generation is critical, and robust methodologies and
different technologies are required. Towards establishing improved understanding and optimised
triggering and control of differentiation processes, analytical techniques such as flow cytometry,
immunohistochemistry, reverse transcription polymerase chain reaction, RNA in situ hybridisation
analysis, and fluorescence-activated cell sorting have contributed much. However, progress in the
field remains limited because such techniques provide only limited information, as they are only able
to address specific, selected aspects of the process, and/or cannot visualise the process at the subcellular
level. Additionally, many current analytical techniques involve the disruption of the investigation
process (tissue sectioning, immunostaining) and cannot monitor the cellular differentiation process in
situ, in real-time. Vibrational spectroscopy, as a label-free, non-invasive and non-destructive analytical
technique, appears to be a promising candidate to potentially overcome many of these limitations as it
can provide detailed biochemical fingerprint information for analysis of cells, tissues, and body fluids.
The technique has been widely used in disease diagnosis and increasingly in stem cell technology.
In this work, the efforts regarding the use of vibrational spectroscopy to identify mechanisms of stem
cell differentiation at a single cell and tissue level are summarised. Both infrared absorption and
Raman spectroscopic investigations are explored, and the relative merits, and future perspectives of
the techniques are discussed.
Keywords: stem cell technology; vibrational spectroscopy; Raman spectroscopy; FTIR absorption
spectroscopy; stem cell differentiation; spectral markers

1. Introduction
Stem Cells and Stem Cell Technology
Stem cells are present within most, if not all, multicellular organisms and are the ultimate drivers
of growth and regeneration. They can be defined as biological cells capable of self-renewal and
differentiation into a variety of cell types. They have been demonstrated to play a critical role in growth
and development during embryogenesis, but also in adult species for the replenishment of potentially
every differentiated mature cell type [1].
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Embryonic Stem Cells (ESCs) were first discovered and characterised in 1981 [2], and subsequently
isolated from human blastocysts in 1998 [3]. Decades previously however, Pierce [4], and also Stevens
and Hummel [5], demonstrated that teratocarcinomas contain cells with multi-lineage potential [6].
These findings were the first steps that led to the isolation of ESCs (Figure 1), and the identification
of their extraordinary ability to proliferate indefinitely in vitro and capacity to differentiate into any
somatic cell type [7]. ESCs are pluripotent cells by definition, and drive the formation of all tissues of
an embryo. However, as reviewed by Lo et al., 2009 [8], the use of human ESCs for research has given
rise to numerous ethical and political controversies since it involves the destruction of human embryos.
Consequentially, the ethical considerations hamper their use in research.

Figure 1. Schematic representation of how embryonic stem cells are derived.

The identification of non-embryonic stem cells, mostly Adult Stem Cells (ASCs) [1], introduced an
alternative and less controversial cell source for stem cell research and its biomedical applications.
ASCs are more specialised than ESCs, and have a limited ability to differentiate to other cell types,
other than the origin tissues [9]. Classified as multipotent stem cells, they are essentially committed
to produce specific cell types: they have a limited, although extremely powerful ability to produce
differentiated cell types, continuing to self-renew over long periods of time. Examples include those in
the brain that give rise to different neural cells and glia, or haematopoietic cells, which can give rise to
different blood cell types. Bone marrow also contains multipotent stem cells that give rise to all types
of blood cells, but no other cell type. A number of characteristics make ASCs the most commonly
used cells in regenerative medicine. The ease of the isolation process and the number of available
tissues, such as umbilical cord, blood, and placenta, means that they can be readily transplanted to a
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site of injury without provoking immune rejection, and they naturally possess immunomodulatory
properties [9].
Mesenchymal Stem Cells (MSCs), observed for the first time in 1968 [10], constitute approximately
30% of bone marrow [11]. They can be easily isolated from a number of tissues [9,12,13], cultured in vitro,
expanded, and induced into differentiation of multiple lineages (Figure 2). Due to their remarkable
capability of extensive in vitro expansion and their natural immunomodulatory properties [14],
their application in modern medicine as a replacement for diseased tissues offers an excellent
alternative to surgery treatments and standard medical therapies [15]. The public clinical trials
database https://clinicaltrials.gov lists more than 200 clinical trials using MSCs for an extensive range of
therapeutic applications including acute myocardial ischemia, stroke, liver cirrhosis, amyotrophic lateral
sclerosis, and immunological diseases [16,17].

Figure 2. Schematic representation of Mesenchymal Stem Cells (MSCs) differentiation process into
three different lineages: Myocytes, Chondrocytes, Osteocytes, Adipocytes, and Neural Cell.

The pioneering technology of Induced Pluripotent Stem Cell (iPSC) was introduced in 2006 by
Takahashi and Yamanaka [18], who showed that adult stem cells can be converted to pluripotent stem
cells through the introduction of four genes [18,19] encoding specific transcription factors. iPSCs are
generated by resetting the fate of somatic cells, and therefore they have the same properties as ESCs.
Because of their ability to self-renew and propagate indefinitely, as well as differentiate into all cell
types of the body [9], they represent a single source of cells that could be used as a replacement for a
vast number of tissues.
By the late 1990s, it became apparent that stem cells could act as a platform for the development of
cell-replacement therapeutics and the fields of regenerative medicine quickly emerged. Cell-replacement
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therapy indeed overcomes the replacement therapy of cells en masse via organ or tissue transplant,
characterised by the acute shortage of donor organs available for transplantation [20].
An alternative approach is ex vivo expansion of stem or progenitor cells which are then transplanted
back into patients, where they undergo a process of renovating their physiological functions and the
adaptive capacities in heterogeneous conditions [21,22].
Relevant scientific advancements, such as the identification of neural stem cells in brain tissue [23]
and the first embryonic cell lines [2] set the stage for the explosion of scientific progressions in the first
decade of the new millennium. By 2007, regenerative medicine and stem cells had led to significant
breakthroughs, such as identification of dermal stem cells in adult skin tissues [24,25], the discovery of
cancer stem cells [26], initiation of the first clinical trial of human embryonic-derived stem cells for
treatment of spinal cord injuries [27,28] (Geron Corporation 2010), and many more. It is clear that
recent advancements in stem cell research have provided a strong foundation of scientific knowledge
setting the stage for optimistically limitless possibilities in tissues replacement therapeutics [1].
Establishing a fundamental comprehension of the genetic and biochemical hierarchy involved in
embryonic and adult stem cell differentiation is critical in the development of new cutting-edge
cell-based and non-cell-based therapeutic strategies. Determining the cell type, limiting the
heterogeneity in the cell populations, and assessing and regulating the differentiation process remain
some of the main challenges that must be addressed for the realisation of alternatives to surgery
treatments and standard medical therapies [29]. Current methodologies for analysis of the stem cell
differentiation process include immunochemistry [30], fluorescence labelling technologies [31–33],
flow cytometry [34], reverse transcription polymerase chain reaction (rt-PCR) techniques [35,36],
and RNA in situ hybridisation analysis. However, these techniques can be costly and time consuming,
require significant user intervention and large volumes of cells, and are generally destructive.
Monitoring the process of stem cell differentiation ideally requires continuous, in situ, characterisation of
individual cells at the subcellular level, as well as population wide screening to monitor the homogeneity
across a population. There is a need for novel, non-destructive, non-invasive techniques, able to
provide in situ molecularly specific information at a cellular and subcellular level with a small quantity
of material.
2. Vibrational Spectroscopy for Stem Cell Characterisation and Differentiation
Vibrational spectroscopy has been extensively explored over the last decades as a diagnostic and
prognostic tool for biomedical applications [37,38]. This technology has the capacity to provide a
detailed molecularly-specific fingerprint, based on the chemical content of a specific tissue or cells [39].
FTIR has become a well-established tool in biophysics for analysis of the structure and interactions of
proteins [40], lipids [41], carbohydrates [42], and nucleic acids [43]. Applications to tissue samples for
(cancer) diagnostic applications were first reported in the early 1990s [44], and since this time a range of
pathologies has been investigated [45–47]. Raman spectroscopy was first applied to biomolecules and
tissues in the 1960s [48]. A variety of constituents has been measured and databases accumulated [49,50],
and by the mid-1970s biomedical applications were explored [51]. Whole cell and tissue studies have
been carried out on a range of pathologies [52–56] and in vivo studies [57,58] have demonstrated the
prospective for diagnostic applications. Raman spectroscopy is able to probe molecular information
from living cells revealing distinct chemical features, and biochemical processes occurring during
cell culture and mitosis [59,60], proliferation [61], differentiation [62–64], adhesion [65], death [66–69],
and invasion [70]. The subcellular resolution of vibrational spectroscopy, and in particular Raman
imaging, has also been exploited to enable the detection of cellular mitochondrial distribution [60] and
phagosomes [71], as well as to monitor the uptake and mechanisms of action of chemotherapeutic
agents [72], and toxicity of nanoparticles [73]. It is not surprising, therefore, that the label free,
non-invasive techniques have attracted increasing attention in the field of stem cell research [29]
for biochemical analysis at the cellular (Section 2.1) and tissue (Section 2.2) level; the aim is to
discriminate between differentiation status, detect chemical alterations before morphological changes
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occur, and identify the possible spectral markers in stem cells and tissues to monitor the process of
stem cell differentiation in situ.
Figure 3a shows an example mean FTIR spectrum of Sprague-Dawley rat mesenchymal stem cells
(bm-MSC), recorded in transmission mode [74]. The more prominent bands have been labelled according
to the typical biochemical origin. The main bands are labelled with accepted assignments of typical
biochemical origin. The so-called “high wavenumber region”, >2500 cm−1 , contains distinctive spectral
features of N-H, C-H, and O-H of proteins, and lipids have been observed in the “high wavenumber
region” (>2500 cm−1 ), while in the “fingerprint region” (<2000 cm−1 ) nucleic acids stretching vibrational
modes at 1070 cm−1 and 1250 cm−1 , Amide I (1650 cm−1 ) and Amide II (1520 cm−1 ), and lipids
content at 1310 cm−1 and 1750 cm−1 . A more detailed list of band assignments is provided in Table 1.
For comparison, Figure 3b shows a mean Raman spectrum recorded from the nuclei of bm-MSCs, using a
the 532 nm laser source of custom-built Raman micro-spectroscopy system described previously [75,76].
The most prominent peaks are annotated and listed in Table 1B. It should be noted that FTIR and
Raman are complementary techniques; this means that although the features in the respective spectra
have similar origin, vibrations of highly polar bonds (e.g., O-H) tend to be highly IR but weakly
Raman active, and vice versa for vibrations of highly polarisable bonds (e.g., C=C). The high spectral
dispersion of common benchtop Raman instruments means that a single detector array window
captures only the fingerprint region, and commonly the high wavenumber region is not recorded.
Raman micro-spectroscopy has intrinsically higher spatial resolution however, enabling subcellular
analysis with the aid of multivariate statistical analysis techniques such as principal components
analysis [77]. As an example, the Raman spectrum of the nucleus in Figure 3b exhibits similarly
prominent signatures associated with proteins and lipids across the fingerprint region, as well as large
peaks related to DNA and RNA at 785 cm−1 .

Figure 3. (a) Representative mean FTIR spectra recorded for mesenchymal stem cells (bm-MSCs) with
classification of relevant peaks and their known association to proteins, nucleic acid, and lipids are
described in Table 1A, (b) Processed mean Raman spectra for bm-MSCs and their known association to
proteins, nucleic acid, and lipids are described in Table 1B [74].
Table 1. Peak assignments for (A) FTIR spectra data (B) Raman spectra data [15,39,63,78–80].
A

Wavenumber

FTIR Peak Assignments

Association

(i)
(ii)
(iii)
(iv)
(v)
(vi)
(vii)
(viii)
(ix)
(x)
(xi)
(xii)

1036
1072
1152
1220–1280
1312
1400
1456
1546
1620–1700
1742
2854
2926

C-C skeletal stretching
PO2 symmetric stretching
C-C and C-O stretching
PO2 asymmetric stretchingAmide III
CH2 stretching
CH3 symmetric stretching
CH3 asymmetric stretching
Amide II
Amide I
Ester, C=O stretching
CH2 symmetric stretching
CH2 asymmetric stretching

Proteins
DNA/RNA
Proteins
DNA/RNA
Phospholipids
Proteins
Proteins
Proteins
Proteins
Lipids
Lipids
Lipids
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Table 1. Cont.
B

Wavenumber

Raman Peaks Assignment

Association

(i)
(ii)
(iii)
(iv)
(v)
(vi)
(vii)
(viii)
(ix)
(x)
(xi)

785–788
1004
1090
1127
1262
1319
1341
1451
1585
1619
1662

Stretching of DNA/RNA related
Phenylalanine
Stretching of DNA related bondsStretching of C-N backbone
Stretching of C-N backboneStretching of C-C
DNA/RNA breathing modesAmide III
CH2 , CH3 twistingDNA/RNA breathing modesCH deformation vibration
DNA/RNA breathing modesCH deformation vibration
CH2 deformation vibration
DNA/RNA breathing modes
Tyrosine; tryptophan
DNA/RNA breathing modesAmide IFatty acids

Nucleic Acid
Protein
Nucleic AcidProtein
ProteinLipid
Nucleic AcidLipid
LipidNucleic AcidProtein
Nucleic AcidProtein
Protein/Lipid
Nucleic Acid
Protein
Nucleic AcidProteinLipid

2.1. Applications of IR and Raman Spectroscopy to Characteristion of Stem Cell Differentiation: Cellular Studies
2.1.1. Embryonic Stem Cells
Embryonic stem cells (ESCs) have been demonstrated to be an incomparable resource
in the development of tissue engineering and regenerative medicine, due to their enormous
differentiation potential in vitro. However, it is important to be able to establish and monitor
differentiated/undifferentiated ratios for applications. Furthermore, alongside their immortality and
self-renewal capacity, ESCs also have the capacity to differentiate in situ into tumours, such as teratomas,
making their use challenging.
Amongst the earliest reports which employed vibrational spectroscopy to study ESCs were
those of Notingher et al. in 2004 [64,81]. The first study investigated the biochemical changes in
murine ESCs (mESCs) throughout the process of differentiation using Raman micro-spectroscopy [81].
Evolving contributions of a number of biomolecules were identified, but the greatest difference between
undifferentiated mESCs differentiated was observed to be in the nucleic acid content. Spectral features
of RNA and DNA, especially in the region 770–880 cm−1 , showed a strong decrease in differentiated
cells by 50%. The results suggested that the differentiated cells were more in the G1 phase of the
cell cycle than S, G2, or M phases, and therefore the proliferation rate was strongly reduced in
the differentiated cells, which developed a mature phenotype, compared with the undifferentiated
ESCs [81]. In the second publication [64], the authors showed how mESCs induced into spontaneous
differentiation could be easily be distinguished from 16–20 day old differentiated cells using Raman
spectroscopy. Differentiated cells showed a different morphology and were confirmed differentiated
through immunostaining assays, while the ratio between the peak areas of RNA and proteins was
calculated and used as a measure of mRNA translation [64]. The nucleic acid content was observed to
be strongly decreased in differentiated cells compared with their mESCs progenitors, suggesting that
the concentration of RNA decreased throughout the differentiation process, following a transcription
for the synthesis of specific proteins. These results provided useful insights for the identification of
significant spectral markers and characterisation of ESCs and their differentiation in vitro. Some years
later, Chan et al. [82] extended this work to human ESCs (hESCs), by probing with Raman their
differentiation into ventricular cardiomyocytes. Consistent with the previous studies, higher nucleic
acid peak intensities were observed in hESCs. The discrimination of hESCs and their progeny according
to RNA levels was confirmed by Principal Components/Linear Discriminant Analysis (PCA–LDA) [82].
Ami et al. [62] performed FTIR micro-spectroscopy to monitor the spontaneous differentiation
of mESCs in their early development within the first 14 days. Spectra were measured at different
times of the differentiation, providing a temporal evolution of the process. Important differences
were observed in the spectra after the fourth day of differentiation, such as in the amide I band
(1700–1600 cm−1 ), suggesting that α-helix and β-turn secondary structures started to be expressed
by the cells, and strong separations into clusters confirmed the observations. The methodology
was proven to be very innovative and efficient, especially for its reproducibility at different time
points. Subsequently FTIR spectroscopy was employed by Tanthanucha et al. to study the neural

Molecules 2020, 25, 5554

7 of 22

differentiation of mouse ESCs. [83]. The main spectral differences were observed in the nucleic acid
region, with contributions also from amide and lipid related bands. Lipid content, probably as an
expression of the developing phosphomembrane, interestingly was seen to decrease (CH3 and CH2
vibrations, region 2852–2959 cm−1 ), whereas glycerophospholipids levels have been showed to increase
with the differentiation process [83]. Heraud et al. [84] published a study on the efficacy of FTIR as
a tool to distinguish hESCs in mesodermal and ectodermal development, observing changes in the
nucleic acid and protein contents after only five days of differentiation. The formation of hepatocytes
has been studied with FTIR by Ami et al. [85] and with synchrotron FTIR micro-spectroscopy [85],
providing detailed chemical compositions of the hepatic progenitors. Interesting variations have been
identified, such as an increased amide I contribution of α-helix proteins, which has been hypothesised
to reflect the emerging presence of albumin in the cells, alongside the appearance of β-sheet proteins
secondary structure.
The results of the first Raman studies on mESCs [64,81,82] confirmed that the changes in RNA
content in cells can be used as a marker to distinguish differentiated cells from their pluripotent
progenitors. This discovery was reinforced by another study reported by Shoulze et al. [86],
which non-invasively assessed the differentiation status of hESCs into heterogenic progeny with
Raman spectroscopy. The study reported that it is possible to evaluate the differentiation status of the
cells by determination of the intensity ratio of certain specific bands (generally contributions of nucleic
acid bands, such as 757/784 cm−1 and 827/811 cm−1 ).
Glycogen bands were demonstrated to play an important role as a discriminant spectral marker
between cardiomyocyte populations and their progenitors [87,88] and in the study published by
Koronov et al. [89], Raman spectroscopy was applied to measure the absolute glycogen content
of hESCs, providing a more rapid and accurate quantification compared to the commercial assay
kit. Koronov et al. also reported a study of cytochemical variations between different colonies
in order to understand the differentiation process [90], and a live in situ analysis of mESCs using
coherent anti-Stokes Raman scattering (CARS) [91]. Moreover, CARS microscopy was employed
by Downes et al. [92] to study the osteoblast mineralisation and lipid production of adipocytes as a
technique capable of discriminating them over their progenitors. More recent studies have focussed on
establishing the specific biomarkers identified in the differentiation process towards hepatocytes [93]
and on identifying the major spectral differences between ESCs and iPSCs [94,95].
2.1.2. Mesenchymal Stem Cell
The ability of MSCs to develop into various cell lineages, the ease with which they can be expanded
in culture, and their innate immunomodulatory properties has led to a great deal of interest in their
use as a therapeutic tool in various treatments. The highest degree of lineage plasticity has been
attributed to bone marrow derived MSCs [96], which can be isolated from adult tissues and induced to
differentiate into the desired lineage. However, the lack of a lineage specific and definitive marker
remains one of the biggest challenges to their use.
Because of the limited supply of an allogenic source of bone and the significant emerging
interest in tissue regeneration based on MSCs, some of the earliest vibrational spectroscopy
studies [97–101] focussed on the osteogenic differentiation. In the study published in 2006 by
Azrad et al. [99], Raman spectroscopy was used to study the effect of two different enhancers (QEVA
and Dexamethasone) of MSCs induced to the osteogenic differentiation process. The differentiation
status was demonstrated by immunochemistry and staining assays, while spectral changes during
the formation and mineralisation of the bone nodules were identified in the Raman signatures.
Amongst the most relevant bands, the greatest changes were observed in the range 950–960 cm−1 ,
corresponding to vibrations of hydroxyapatite, suggesting the presence of calcium phosphate species
(ACP amorphous cp and OCP octacalcium), which are markers for mineralisation. In another study
the following year, Krafft et al. probed the osteogenesis of human MSCs with FTIR, with and
without osteogenic stimulation [102]. FTIR spectroscopic signatures and differentiation markers were
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identified, such as that at 1100 cm−1 , indicating the presence of calcium phosphate salts, while the
undifferentiated cells (non-stimulated) showed increased levels of glycogen content (peak intensities at
1025, 1080, and 1152 cm−1 ) [102]. Gentleman et al. [97] observed the development of mineralisation
nodules within 28 days of differentiation; morphological changes were illustrated by alizarin red staining
and SEM imaging, while Raman micro-spectroscopic signatures of the mineralised nodules were
compared with native bone. Both of them were dominated by the band at ~960 cm−1 , corresponding to
PO4 3− vibrations. Raman micro-spectroscopy has also been employed to record 28-days human MSCs
derived from osteogenic differentiation by McManus et al. [100]; positive changes in collagen type
II and in phosphate content were reported, and the results were validated by specific rt-PCR and
staining tests. The following year, McManus et al. [101] demonstrated through Raman spectroscopy
that osteoblast-like cells have similar attributes to native bone, and therefore could potentially be used
as a model for human primary osteoblasts.
Adipogenic differentiation was also investigated with both FTIR [14], and surface-enhanced
Raman spectroscopy (SERS) over a period of 22 days [103]. In the first study, MSCs were induced
into differentiation, and pre-adipocytes were characterised at different time points. On the third
and fifth days, specific peaks derived from ester bonds of triglycerides (1739 cm−1 ) appeared to
be increased over the undifferentiated progenitors. Moody et al. [103] observed the adipogenesis
process of human-adipose-derived stem cells over a period of 22 days, monitoring the intracellular
accumulation of lipids towards the completion of the differentiation process.
Moreover, chondrogenic differentiation of hMSCs has been monitored with synchrotron FTIR
micro-spetroscopy [104] and with Raman micro-spectroscopy up to 21 days [105,106]. The major
differences were observed in collagen at 1338 cm−1 (amide III band), PO− stretching, and proteoglycan
protein related bands at 1245 cm−1 1065, 1079, and 1300 cm−1 (S–O stretching band) [104,106].
However, as MSCs develop into chondrocytes, they secrete extracellular matrix (ECM) which
encompasses them, forming the dense and complex framework that constitutes the cartilaginous
scaffold. Therefore chondrogenesis has been more frequently studied from the point of view of
cartilage ECM formation [107], and will be discussed further in Section 2.2. FTIR has also been utilised
successfully to discriminate functional hepatocytes [85] and hematopoietic stem cells [68].
FTIR has been used alongside Raman spectroscopy to discriminate de-differentiated smooth
muscle cells (ddSMCs) from undifferentiated stem cells and their myogenic and osteogenic progeny,
in order to better elucidate the mechanism of accumulation of SMC-like cells in the vessel and
obstruct the blood flow [74]. Significant spectral differences were observed between bone marrow
MSCs, their progeny, and ddSMCs by FTIR and PCA, suggesting that the cell populations are clearly
distinct. The use study demonstrated the potential advantages of the complementarity of FTIR and
Raman micro-spectroscopy in parallel studies, whereby the lower resolution of the FTIR imaging
is used for screening of larger populations, whereas the subcellular resolution of Raman can be
employed to better elucidate the underlying mechanisms of differentiation [74]. Both FTIR and Raman
spectroscopy have been successfully used to distinguish between hESCs and human Mesenchymal
Stem cells (hMSCs) [108]. Moreover, the complementarity of these techniques has been highlighted
and consistently reviewed [29,38,109].
2.1.3. Induced Pluripotent Stem Cells
iPSCs have the potential to revolutionise many aspects of stem cell science and regenerative
medicine by offering multiple disease modelling and therapeutic options that were not previously
possible. Recent studies have revealed a trace of epigenetic memory preserved in iPSCs, according to the
somatic cell of origin [110,111], which can facilitate or hamper their differentiation fate. Their pluripotent
capacity is assessed by specific phenotypic profiling, or by functional assays such as teratoma induction
and global genes expression detection [112]; however methodologies able to identify iPSCs by their
biophysical characteristics are still lacking.
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In 2012, Tan et al. [94] published a significant study on using Raman spectroscopy for
the comparison and assessment of the differences between hESCs, hiPSCs, and non-specifically
differentiated hESCs over a period of 20 days. The study demonstrated that spectra of hESCs more
closely resemble those of induced cells than the differentiated progeny. In fact, spectra of hiPSCs
and hESCs were found to be extremely similar, and both were distinguishable from differentiated
hESCs (non-specifically differentiated) in terms of relative Raman peak intensities. The main spectral
differences were identified in the protein content (757 cm−1 , 876 cm−1 , 1003 cm−1 , 1032 cm−1 ) of nucleic
acids (783 cm−1 ) and lipids (699 cm−1 , 717 cm−1 ) [94].
FTIR spectral profiles of differentiated pancreatic cells (DPCs) [113] and kidney cells (DKCs) [114]
were compared with their pluripotent progenitors, and analysed at different maturation stages
(11, 17, and 21 days [113], and 0, 10, 15, and 21 days [114] respectively) alongside genetic, phenotypic,
and biochemical analysis by real-time quantitative PCR (RT-qPCR) and immunocytochemistry assays.
PCA of FTIR spectra was used to characterise chemical and structurally mouse pluripotent stem cells
(miPSCs) and their differentiation process to DKCs and DPCs. Distinct differences were observed
between the cell lineages, including in the protein amide (1700–1500 cm−1 ) and carbohydrates and
nucleic acid regions (1200–850 cm−1 ), a significant increase in the intensity of the bands corresponding to
glycogen (1030 cm−1 and 1080 cm−1 ) [113,115] in DPCs, compared to miPSCs, and the C=O esteric band
of lipids [114], which was seen to be more intense than in miPSCs, probably due to phosphatidylcholine
synthesis throughout the metabolic kidney development. Furthermore, a recent study with Raman
spectroscopy identified, at the single cell level, the most relevant differences between hiPSCs and hiPSC
cell-derived neurons [116], developmental stages of the neural lineage differentiation were investigated,
and the most prominent changes were found in the bands at 400 and 417 cm−1 (saccharides), 480 cm−1
(glycogen), 746 cm−1 , 1125 cm−1 , and 1580 cm−1 (cytochrome c), 720 and 780 cm−1 (DNA/RNA),
1003 and 1030 cm−1 (phenylalanine), 1295 and 1440 cm−1 (lipids), and 1660 cm−1 (proteins) [116].
Although undifferentiated ESCs and fully reprogrammed iPSCs signatures were earlier observed
to be undistinguishable [94], the study by Parrotta et al. [95] of embryonic and induced pluripotent stem
cells performed with Raman spectroscopy highlighted major differences between the two (Figure 4).
Their main discoveries revealed differences in nucleic acid content, shown by the strong positive peaks
at 785, 1098, 1334, 1371, 1484, and 1575 cm−1 , which are enhanced in human induced pluripotent
stem cells, potentially due to the different epigenetic background [95]. HiPSCs and hESCs have been
previously demonstrated to express largely similar features, although metabolic differences between
the two pluripotent lines have also been hypothesized [94]. These recent results demonstrated that,
even though the spectral signatures of hiPSCs closely resemble those of hESCs, Raman spectroscopy
was well suited for identifying the small biochemical differences that discriminate them.
2.2. Applications of IR and Raman Spectroscopy to Characteristion of Stem Cell Differentiation: Tissue Studies
Vibrational spectroscopy using both FTIR and Raman spectroscopy has been used over the past
few years in the study of the mechanisms underlying tissue regeneration. However, the biggest
challenge with many current analytical techniques is that they often involve disrupting the sample
growth, and therefore the very process under investigation (e.g., tissue sectioning, immunostaining).
As a non-destructive, label-free technique, vibrational spectroscopy can determine the molecular
composition, detect chemical alterations before morphological changes are evident, and discriminate
between a variety of tissue types. This technology has been used to detect cellular differentiation [117]
and apoptosis [118], to assess the effects of post-transplant organ regeneration [119,120], offering great
promise for in vitro and in vivo diagnosis potential applications and eliminating or reducing the need
for biopsies.
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Figure 4. Raman imaging of typical human Embryonic Stem Cells (ESCs) and Induced Pluripotent Stem
Cells (iPSCs). Colour-reconstituted Raman images of human embryonic stem cells (hESCs, upper left
panel) and human induced pluripotent stem cells (hiPSCs) (upper right panel). White scale bar = 5 µm.
Small insets show corresponding bright-field images recorded after Raman scanning. Raman peak at
785 cm–1 (DNA/RNA bases) mapped in red, 1670 cm–1 (proteins) in blue, 2850 cm–1 (lipids) in green,
and a combination of 748 and 1585 cm−1 (cytochrome C) in magenta. hiPSCs exhibit a much higher level
of DNA/RNA bases in well-defined regions of the cell. Curves in the lower panel are average spectra of
hESCs (top curve) and hiPSCs (bottom curve), where the peaks used for the colour-reconstituted images
are indicated with the corresponding colour (Reproduced from Parrotta et al. [95] under Creative
Commons CC BY license).

Stem cells of the intestinal crypt have been widely investigated, aiming to identify reliable
markers for accurate discrimination of stem cell location from the transient-amplifying (TA) cells
within the crypts, and differentiated cells [121]. In 2008 [122], FTIR spectroscopic imaging was
used to identify the locations and spectral signatures of stem cell regions of human intestinal crypts
(Figure 5). Spectral mapping was used, and significative differences within the three tissue locations
were identified, especially for the vibrations of DNA (1225 cm−1 , 1080 cm−1 ). Small and large
intestinal crypts showed the most intense PO− signals, which were identified as the most robust IR
spectral marker for stem cell identification. Bentley et al. [123] and Kelly et al. [124] successfully
investigated the human corneal epithelium with synchrotron-based FTIR spectroscopy, revealing the
major biomarkers responsible for the distinction between TA cells, terminally-differentiated cells
(TD), stem cells, and corneal squamous cell carcinoma [124]. Differences were identified between TA,
TD, and stem cells due to protein associated peaks and RNA expression [123], and carbohydrate and
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glycogen regions [124]. Moreover a spectral profile of squamous cell carcinoma cells was defined,
defining their highly proliferative nature and capability of giving rise to a TA cell-like class [124].

Figure 5. Localisation of the putative stem cell region in an IR spectral image (resolution of 8 µm × 8 µm)
map of intestinal crypts obtained using synchrotron FTIR micro-spectroscopy; a comparison with
proposed immunophenotypical markers. (A): Two-dimensional (2D) map of a small intestinal crypt,
smoothed at the wavenumber 1080 cm−1 and superimposed on the unstained region analysed.
(B): A representative photomicrograph of a parallel section containing small intestinal crypts stained
with mouse monoclonal anti-β-catenin antibody. Note nuclear immunoreactivity in Paneth cells,
identified by their pyramidal shape and “foamy” cytoplasm. (C): A representative photomicrograph of
a parallel section containing small intestinal crypts stained with rabbit polyclonal anti-CD133 antibody.
Weak immunoreactivity varied little along the length of the crypt. (D): 2D map of a large intestinal
crypt, smoothed at the wavenumber 1080 cm−1 and superimposed on the unstained region analysed.
(E): A representative photomicrograph of a parallel section containing large intestinal crypts stained
with mouse monoclonal anti-β-catenin antibody. In a single crypt two nuclei (*) showed weak nuclear
immunoreactivity. (F): A representative photomicrograph of a parallel section containing large intestinal
crypts stained with rabbit polyclonal anti-CD133 antibody. Weak cytoplasmic immunoreactivity was
observed throughout the length of the crypt. Spectral intensity is represented as thermal color changes
(blue < green < yellow < red). The synchrotron FTIR micro-spectroscopy experiments were carried out
at the European Synchrotron Radiation Facility. (Reproduced with permission [122]).

In recent years, there has been a growing interest in the use of vibrational spectroscopy
to characterise the extracellular matrix (ECM). A complex network of biomolecules, such as
glycosaminoglycans (GAGs), proteoglycans, and collagen are deposited in the ECM of tissues, and the
possibility to specifically assess these elements can be applied across a broad range of applications,
including tissue engineering [125]. Raman spectroscopy represents a particularly powerful approach
for bone ECM characterisation, as reported by Draper et al. [126] and Mandair et al. [127], who used
this technology extensively to analyse how changes in bone composition and structure influence tissue
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level bone mechanical properties. Bone ECM has a highly crystalline mineral structure, which exhibits
very strong Raman scattering signal, especially the band ∼960 cm−1 (ν1 PO3− ), characteristic of the
apatite crystal content. Furthermore, FTIR spectroscopy has been used to establish a new protocol
for high quality bone formation and characterization, with the potential to be applied to bone tissue
engineering [128].
The cartilaginous ECM is extremely rich in collagen type I and IX, and XI fibers [129],
interspersed with GAG macromolecules, and it is produced and maintained by the chondrocytes.
The loss of ECM homeostasis and the degradation of cartilage lead to severe diseases, such as
osteoarthritis (OA) [130], making the detection of the involved factors a matter of great importance.
Lim et al. [131] used Raman micro-spectroscopy to study the biomolecular changes associated with
cartilage damage prior to visible histological changes, observing a decrease in the GAGs collagen
(Amide III 1264–1274 cm−1 ) content, in early cartilage damage. Pudlas et al. [106] identified the
chondrocytes differentiation state by the study of proteoglycans and GAGs in different zones of
cartilaginous ECM, both porcine and human, recognising well-defined Raman spectral biomarkers.
Major bands at 1065 (SO−3 ), 1079 (C–C stretch vibrations), and 1300 cm−1 (lipids) were identified and
classified of high interest for the differentiation status assessment [106].
A recent study using Raman spectroscopy analysed the higher wavenumber region of the spectrum
between 2700 and 3800 cm−1 , in which the peaks were seen to be correlated with increases in the
permeability and variations in the aggregate modulus of articular cartilage [132]. The study indicates the
water content in human articular cartilage can be (inversely) correlated with the mechanical properties
of cartilage and could potentially be used as an in vivo probe of diseased tissues (OA associated).
3. Future Perspectives on the Use of Vibrational Spectroscopy for Stem Cell Technology;
Data Analysis and Machine Learning, 3D Cultures and Nanotechnology
Research on regenerative medicine and development of novel therapeutic targets has immensely
accelerated following the introduction of stem cell technologies. Following the identification of
different types of stem cells, their potential to differentiate into different lineages has led to escalated
research efforts, and stem cell technology has attracted considerable attention due to its potential
to extend recovery capabilities of the human body following many diseases and injuries which are
not currently treatable by current medical procedures. Despite their enormous potential in clinical
research, these new technologies still hold many unknowns, and applications remain limited by a
lack of fundamental understanding of their differentiation mechanisms and ability to fully regulate
the triggering of their differentiation. The importance of the use of multi-disciplinary approaches by
employing new emerging technologies to understand their mechanism of action is therefore beyond
question. In this review, we aimed to introduce the different types of stem cells and their potential
uses for clinical applications, as well as collective efforts to date to employ vibrational spectroscopic
techniques, both at the single cell and tissue level, to understand and control their mechanism of
differentiation. Undoubtedly, there is still room for improvement and research efforts will continue in
an attempt to harness the full benefits of stem cell technology. This section will focus on the future
perspectives and possibility of extending current applications and incorporation of other technologies
to improve our understanding of the differentiation process.
Identification of stem cells in complex biological environments, based on their biochemical
characteristics and investigation of spectral markers of the differentiation process have been amongst
the main targets of stem cells research. In the context of basic research and proof-of-concept
studies, vibrational spectroscopy has provided information regarding the biochemical composition
of stem cells and introduced spectral markers to monitor differentiation, in a label free and
non-destructive way. However, conflicting or inconsistent results from the studies regarding identified
biomarkers and commonality of markers at different differentiation stages has made the applications
limited. Therefore, more systematic approaches, a cross-check of differentiation markers during
differentiation into various lineages and time dependant investigation of spectral marker evolutions
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will be critical to move forward. Notably, while spectral signatures of biomolecules such as RNA,
DNA, proteins carbohydrates, and lipids have been identified at subcellular, cellular, ECM, and tissue
levels, a holistic spectroscopic picture of the biochemical evolution from stem cell triggering, through the
differentiation process, to tissue formation, is still lacking. Ultimately, protocols for continuous in situ
monitoring of live stem cell differentiation, maturation, and tissue formation are required, but in the
fields of both IR and Raman spectroscopy, novel technologies continue to emerge. Traditionally, it is
considered that the relatively strong absorption of water in the mid infrared region favours the
use of Raman, rather than IR, micro-spectroscopy for in vitro monitoring [39]. Live cell imaging
has been performed in vitro using higher power sources such as synchrotrons [133], and emerging
technologies based on quantum cascade lasers have brought such higher powers to the benchtop for
more routine infrared analysis of cells and tissues [134]. Water is a relatively weak scatterer, and live
cell imaging is relatively routine, at least over limited time periods [135]. While standardisation of
interlaboratory protocols for Raman spectroscopic characterisation of biological materials is still under
development [136], instrumentally, the principle challenge is that of the sample containment, in an
appropriate viable environment. Microscope stage incubation units for live cell measurements are
increasingly available [88,137–139], and Raman spectroscopic systems themselves continue to evolve.
Fibre based systems are increasingly being evolved for high spectral quality in situ, and even in vivo
biomedical applications [38], and thus the prospect that stem cells can be identified, and their evolution
monitored in an in vivo environment, is real.
Beyond basic research, the prospective applications of Raman spectroscopy in the development
of cell therapies has recently been reviewed by Rangan et al. [140]. It is noted that the broad impact
benefit is potentially at the stages of monitoring the stages of cell harvesting, cell expansion, and cell
generation. Numerous studies on stem cells [15,86,89,91], and analysis of the cells of the immune
system [141] have validated the applicability of Raman spectroscopy to performing highly specific
cell characterisation. High throughput applications have also been demonstrated [142], and therefore
it can be anticipated that the technique can play a role in analysing and validating the quality of
therapeutic cells, and so in monitoring the purification, enrichment, and isolation of cell populations.
Raman spectroscopy is already implemented in a number of areas as an online tool for process analytical
technology (PAT) [143], and thus can also be employed for routine, automated monitoring of microbial
or xenobiotic contamination in scaled up manufacturing processes.
Realisation of clinical applications of vibration spectroscopy have, to date, been relatively slow [38].
However, the areas of analysis of blood for disease diagnostics, as well therapeutic monitoring, have been
particularly active of late [144–146], as has that of in vivo probes for both diagnostic applications
and intraoperative determination of resection margins [147–149]. It can be projected therefore that
vibrational spectroscopy can add value to the cell therapy pipeline, to monitor therapeutic efficacies
and immunoresponses.
Moreover, introduction of advanced data analysis techniques and machine learning strategies
to extract the information from vibrational spectroscopy data sets can bring new insights into stem
cell technology. Pre-processing and data analysis have been accepted to be undeniable components
of vibrational spectroscopic techniques in order to improve spectral quality by reducing background
and measurement artefacts, as well as to extract biochemical and hierarchical information from data
sets. The complexity of the measured environment combined with the dimensionality of data sets led
researchers to apply non-supervised and supervised multivariate analysis techniques, such as principal
component analysis, partial least squares regression and partial least-squares-discriminant analysis.
It should also be noted that, to date, research on stem cells utilising vibrational spectroscopy
has mainly been performed on two-dimensional (2D) cultures. Although 2D in vitro culture models
have been widely used due to their convenience and high cellular viability and provided valuable
information about the variety of cellular processes [150], they lack the complexity of the in vivo
biological environment in which cells grow [151]. In vivo, cells are surrounded by an extracellular
matrix with acts as a support, provides mechanical properties and facilitates communication between
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cells [152]. This surrounding organisation of the in vivo environment strongly influences cell behaviours
such as proliferation, metabolism, survival, resistance to therapeutics, and differentiation in the case of
stem cells [153,154]. Therefore, the use of 3D substrates and/or co-cultures in spectroscopic studies of
stem cells should be explored more extensively.
Additional efforts to understand their mechanism of differentiation, identification of biomarkers,
and spectral markers of differentiation will open a new door to control their differentiation processes and
ultimately will bring new insights to their clinical use. In this respect, merging stem cell technologies
with other emerging technologies, such as nanotechnology, can provide new strategies to control
and direct their differentiation. The ideas of using nanomaterials for biomedical applications and to
understand cellular dynamics have gained immense interest [155]. Their unique physicochemical
and optical properties, as well as ease of interaction with biological materials and living systems,
has precipitated the idea of using them as drug carrying agents and targeting agents. Most nanoparticles
have been shown to be taken up readily by cells and trafficked through subcellular compartments.
In addition to their transport inside the cells, these nanomaterials have been shown to carry messages
and activate and/or inhibit biological processes inside the cell. The effect of nanoparticles on the
suppression and/or enhancement of the differentiation has been shown by various groups (for a detailed
review on the topic, please see Dayem et al., 2016) [156]. Gold nanoparticles have been demonstrated
to enhance the differentiation of stem cells into osteogenic and neural lineages, whereas they suppress
adipogenic differentiation [157,158]. Moreover, in individual studies, the enhancing effects of silver
nanoparticles and dexamethasone-loaded carboxymethyl chitosan/polyamidoamine dendrimers on
differentiation have been shown, albeit based on different mechanisms of action [159,160]. Based on the
research to date, it is not unreasonable to predict that using nanomaterials during the differentiation
process will show an impact on the overall process and could change the commitment of the stem cell.
In the future, more systematic investigation of nanoparticle-stem cell interactions can provide more
insight to their clinical applications.
In all aspects of stem cell research, both Raman and FTIR micro-spectroscopies have demonstrated
their potential to contribute additional insight into the process of stem cell triggering, the evolution of
cellular phenotypes during differentiation, and the process of tissue generation. The non-invasive,
label free nature of the techniques means that either can be employed to monitor cell and/or tissue
growth in situ. The complementarity of the two techniques has been demonstrated to integrate the
capacity to perform studies from subcellular to large population screening. Beyond fundamental
research, potential clinical applications have already been explored, with the promise of translation to
in vivo monitoring of tissue regeneration and stem cell therapeutics.
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